Diagnosis & Treatment Blogs
-
Communication is critical to a positive doctor-patient relationship. Knowing the right questions to ask helps ensure you leave your appointments with the information and answers
-
World Cancer Day and #CloseTheCareGap in Lung Cancer Screenings
For World Cancer Day this year, the Union for International Cancer Control presents the #CloseTheCareGap initiative. February 4, 2023 will be a day focused on promoting equity in -
Targeted Therapy Options for Patients with EGFR Exon20+ NSCLC
Researchers have made tremendous progress in treating lung cancer by identifying key mutations in genes that drive the growth of lung cancer. Once these “driver” mutations are -
Improving Treatment for KRAS-mutated Lung Cancer
While targeted therapies have emerged in the past decade to improve treatment of non-small cell lung cancer (NSCLC) with some types of driver mutations (such as EGFR and ALK), lung
-
The 2021 Global Lung Cancer Therapy Landscape
On June 1st, 2022, LUNGevity Foundation hosted a Facebook Live to discuss our manuscript titled “ The 2021 Global Lung Cancer Therapy Landscape” published in the Journal of
-
Palliative Care 101 - Improving Quality of Life While in Treatment
Palliative care, or supportive care, often misunderstood as only end-of-life care, improves patients' quality of life while undergoing treatment. The goal of palliative care is to
-
Discovering a New Approach to Treat Metastatic NSCLC
Lung cancer continues to be the number-one cause of cancer deaths in the United States. In the past decade, we have seen great improvements in the treatment of metastatic lung
-
KRAS: How It Started vs. How It’s Going
On May 28, 2021, the United States Food & Drug Administration (FDA) approved sotorasib as the first targeted therapy for patients with KRAS G12C-positive non-small cell lung cancer (NSCLC).
-
Understanding Lung Cancer Staging
For people with lung cancer, one of the first steps in navigating their diagnosis comes from understanding what their lung cancer stage means for the future of their treatment.
-
Expanded Coverage of Lung Cancer Screening with Low-Density Computed Tomography
On February 10, 2022, the Centers for Medicare & Medicaid Services (CMS) issued a National Coverage Decision to expand reimbursement for lung cancer screening with low-density
-
A Work in Progress: Developing Personalized Medicine for SCLC
Personalized medicine, in which the molecular profile of each patient’s tumor helps customize the course of treatment, has been useful in treating many types of cancer, including
-
Progress in Targeting MET Drivers in Advanced NSCLC
MET is a gene that encodes for a MET protein. It is an important signaling protein known to play many different important roles, from the development of embryos to wound healing in